In today's complex healthcare landscape, real-world data (RWD) is increasingly valued for its information regarding diverse patient populations. Clinical research sites are an essential part of the RWD collection process, which increasingly leverages advanced technologies that enhance data collection, analysis and informed decision-making.
RWD can accelerate development timelines and augment clinical trial insights with key observational results from a wider and more diverse range of
Read More
real-world data (RWD)
ConcertAI Acquires CancerLinQ to Expand Real-World Data and AI Solutions for Cancer Care
What You Should Know:
- ConcertAI, a developer of AI-powered healthcare solutions, announced today the acquisition of CancerLinQ, a subsidiary of the American Society of Clinical Oncology (ASCO).
- This strategic move will significantly enhance and expand CancerLinQ's capabilities, unlocking the potential of real-world data and next-generation AI to revolutionize cancer care and accelerate clinical research.
CancerLinQ Background
CancerLinQ represents one of the largest oncology
Read More
Syapse and FDA OCE Collaborate to Advance Real-World Evidence in Oncology
What You Should Know:
- Syapse®, a leading real-world evidence (RWE) company dedicated to extinguishing the fear and burden of serious diseases, and the FDA Oncology Center of Excellence (OCE) today announced the renewal of their four-year collaboration agreement.
- This expanded strategic partnership aims to collaboratively develop and implement research projects that advance the use of real-world data (RWD) and explore the potential of RWE to inform regulatory decisions in
Read More
Veradigm Invests $30M in Behavioral Health Co. Holmusk
What You Should Know:
- Veradigm Inc. (NASDAQ: MDRX), a provider of healthcare data and technology solutions, announced it has made a $30M strategic investment in Holmusk, a global behavioral health real-world evidence company. The strategic investment builds on the strengths of each company to fuel innovation in behavioral health and create the evidence needed to move the field forward.
- In this new phase of the collaboration, cohorts of millions of behavioral
Read More
Atropos Health Partners, Janssen Partner to Accelerate Clinical Trials with RWD
What You Should Know:
Atropos Health, a pioneer in evidence-based healthcare known for its Green Button Clinical Informatics Consult Service, today announced an agreement with Janssen Research & Development, LLC (Janssen), a Johnson & Johnson company, to help accelerate clinical development with real-world data analysis.Building upon an existing collaboration, under the new agreement, Atropos and Janssen data scientists will utilize Atropos’s software platform to interrogate
Read More
COTA Launches EHR Dataset to Advance Generative AI Models for Cancer Care
What You Should Know:
- COTA, a real-world oncology data and analytics company announced the launch of Vista, a large-scale automated EHR dataset to accelerate cancer research and the deployment of trusted generative AI in cancer care.
- Vista will provide biopharmaceutical companies with timely insights from real-world data sources to bring life-saving therapies to market faster. Vista uses automated data abstraction techniques, machine learning algorithms, and medical expert
Read More
Atropos Health Goes Global With New Funding from Samsung, Presido Ventures
What You Should Know:
Atropos Health, a pioneer in evidence-based healthcare known for its Green Button Clinical Informatics Consult Service, today announced that it has completed strategic financing from Presidio Ventures, the venture arm of Sumitomo Corporation, Samsung Next, a venture arm of Samsung Electronics, Gaingels, and others.The funding enables Atropos Health to accelerate commercial and development opportunities outside the U.S., using its proprietary technology and approach. The
Read More
OM1 Launches Parkinson’s Disease Real-World Datasets for Neuroscience
What You Should Know:
Today, OM1 announced the launch of its Parkinson’s Disease datasets, enhancing its Mental Health & Neuroscience Real-World Data Network.OM1’s Mental Health & Neuroscience Real-World Data Network, which already includes robust datasets focused on Major Depressive Disorder, Multiple Sclerosis, Bipolar Disorder I and Schizophrenia, will further expand to include Alzheimer’s Disease in the coming months.
Parkinson’s Disease Premium Dataset
Nearly
Read More
FDA Taps Flatiron for 5-Year Real-World Data Collaboration
What You Should Know:
Flatiron Health today announced its renewed collaboration with the Oncology Center of Excellence (OCE) of FDA to jointly develop and implement specific research projects to advance the use of Real World Data (RWD) and explore the potential strengths and limitations of using Real World Evidence (RWE) for regulatory purposes.The partnership will specifically evaluate RWD study designs and analytic methods through the collaborative development of priority, clinically
Read More
PicnicHealth Enters Oncology Real-World Data Market
What You Should Know:
PicnicHealth, a patient-centered health technology company, today announced its entry into the real-world data market for oncology.Drawing from its success working with chronic disease patients to create robust datasets, the company aims to advance oncology research using a similar model by working directly with people living with cancer to collect and structure their medical records data. PicnicHealth is actively exploring partnerships to develop new patient
Read More
